Your browser doesn't support javascript.
loading
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial.
Yong, Kwee; Wilson, William; de Tute, Ruth M; Camilleri, Marquita; Ramasamy, Karthik; Streetly, Matthew; Sive, Jonathan; Bygrave, Ceri A; Benjamin, Reuben; Chapman, Michael; Chavda, Selina J; Phillips, Elizabeth H; Del Mar Cuadrado, Maria; Pang, Gavin; Jenner, Richard; Dadaga, Tushhar; Kamora, Sumaiya; Cavenagh, James; Clifton-Hadley, Laura; Owen, Roger G; Popat, Rakesh.
Affiliation
  • Yong K; Cancer Institute, University College London, London, UK; Clinical Haematology Department, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: kwee.yong@ucl.ac.uk.
  • Wilson W; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • de Tute RM; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
  • Camilleri M; Cancer Institute, University College London, London, UK; Clinical Haematology Department, University College London Hospitals NHS Foundation Trust, London, UK.
  • Ramasamy K; Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Oxford, UK.
  • Streetly M; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sive J; Clinical Haematology Department, University College London Hospitals NHS Foundation Trust, London, UK.
  • Bygrave CA; Department of Haematology, University Hospital of Wales, Cardiff, UK.
  • Benjamin R; Haematology Department, Kings College Hospital, London, UK.
  • Chapman M; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK.
  • Chavda SJ; Cancer Institute, University College London, London, UK.
  • Phillips EH; Haematology Oncology Department, University of Manchester, Manchester, UK.
  • Del Mar Cuadrado M; Cancer Institute, University College London, London, UK.
  • Pang G; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Jenner R; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Dadaga T; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Kamora S; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Cavenagh J; Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
  • Clifton-Hadley L; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Owen RG; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
  • Popat R; Clinical Haematology Department, University College London Hospitals NHS Foundation Trust, London, UK.
Lancet Haematol ; 10(2): e93-e106, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36529145
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Elettaria / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Lancet Haematol Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Elettaria / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Lancet Haematol Year: 2023 Document type: Article Country of publication: